|Title:||Methods of inhibiting transplant rejecton in mammals using rapamycin and derivatives and prodrugs thereof|
|Abstract:||This invention provides a method of inhibiting organ or tissue transplant rejection in a mammal in need thereof, comprising administering to said mammal a transplant rejection inhibiting amount of rapamycin. Also disclosed is a method of inhibiting organ or tissue transplant rejection in a mammal in need thereof, comprising administering to said mammal (a) an amount of rapamycin in combination with (b) an amount of one or more other chemotherapeutic agents for inhibiting transplant rejection, e.g., azathioprine, corticosteroids, cyclosporin and FK506, said amounts of (a) and (b) together being effective to inhibit transplant rejection and to maintain inhibition of transplant rejection.|
|Inventor(s):||Calne; Sir Roy (Cambridge, GB2)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Publication Date|
|Austria||135215||Mar 15, 1996|
|Australia||5686590||Jan 31, 1991|
|Australia||638253||Jun 24, 1993|
|Canada||2018287||Dec 06, 1990|
|Germany||69025803||Apr 18, 1996|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.